# NP Life Sciences Health Industry Group Inc.

NP Life Sciences Health Industry Group Inc. is a public company listed on OTC as ACAT, headquartered in Danville, CA, United States.

## Company overview

- **Legal name:** NP Life Sciences Health Industry Group Inc.
- **Former names in filing history:** GJ Culture Group US, Inc. (2019-07-09 to 2022-09-29)
- **Classification:** Public company
- **Industry (SIC):** 8200 — Services-Educational Services
- **Headquarters:** Danville, CA, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **Ticker:** OTC: ACAT
- **SEC CIK:** 0001781726

## About

NP Life Sciences Health Industry Group Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001781726, and its reported industry is Services-Educational Services. In 10-K filed on 2024-04-16, it reported annual revenue of USD 164,621; net income of USD -2,935; total assets of USD 76,864 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $164,621 (USD 164,621)
- **Net income:** -$2,935 (USD -2,935)
- **Total assets:** $76,864 (USD 76,864)
- **Cash and equivalents:** $70,614 (USD 70,614)
- **Operating cash flow:** -$73,607 (USD -73,607)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $102,002 (USD 102,002)
- **Net income:** -$18,856 (USD -18,856)
- **Total assets:** $127,784 (USD 127,784)
- **Cash and equivalents:** $121,859 (USD 121,859)
- **Operating cash flow:** $93,873 (USD 93,873)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $34,992 (USD 34,992)
- **Net income:** -$65,677 (USD -65,677)
- **Total assets:** $38,411 (USD 38,411)
- **Cash and equivalents:** $27,986 (USD 27,986)
- **Operating cash flow:** -$90,625 (USD -90,625)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $15,000 (USD 15,000)
- **Net income:** -$131,065 (USD -131,065)
- **Total assets:** $118,611 (USD 118,611)
- **Cash and equivalents:** $118,611 (USD 118,611)
- **Operating cash flow:** -$124,322 (USD -124,322)

## Recent SEC filings

- Form 10-K — filed 2024-04-16 — period 2023-12-31
- Form 10-Q — filed 2023-11-14 — period 2023-09-30
- Form 10-Q — filed 2023-08-14 — period 2023-06-30
- Form 10-Q — filed 2023-05-15 — period 2023-03-31
- Form 10-K — filed 2023-04-18 — period 2022-12-31
- Form 10-Q — filed 2022-11-14 — period 2022-09-30
- Form 8-K — filed 2022-09-08 — period 2022-09-02
- Form SC 13D — filed 2022-09-02
- Form SC 13D — filed 2022-09-02
- Form 10-Q — filed 2022-08-15 — period 2022-06-30
- Form 10-Q — filed 2022-05-23 — period 2022-03-31
- Form 10-K — filed 2022-04-15 — period 2021-12-31

---

Updated: 2026-10-23T06:52:41Z

Canonical page: https://altss.com/profile/np-life-sciences-health-industry-group-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology